Grants per year
Personal profile
Training Experience
| 1996 | Fellowship, Wayne State University |
| 1999 | Internship, Wayne State University |
| 2002 | Residency, University of Chicago Hospitals |
| 2004 | Fellowship, University of Chicago Hospitals |
Education/Academic qualification
MD, Medical Academy, Sofia, Bulgaria
… → 1991
Fingerprint
Dive into the research topics where Roumen Deltchev Balabanov is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 5 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
-
Prot #101MS329: A Randomized, Controlled, Open-Label, Rater-Blinded, Phase 3b Study of the Efficacy, Safety, and Tolerability of 6-Week Extended Interval Dosing of Natalizumab (BG00002) in Subjects With Relapsing-Remitting Multiple Sclerosis Switching Fro
Quintiles, Inc., Biogen MA Inc.
6/14/19 → 6/14/22
Project: Research project
-
Identifying Immune Cell Surface Markers in Multiple Sclerosis and Other Autoimmune Diseases of the Nervous System
3/22/19 → 3/22/22
Project: Research project
Research Output
-
Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy
Burt, R. K., Balabanov, R., Tavee, J., Han, X., Sufit, R., Ajroud-Driss, S., Jovanovic, B., Quigley, K., Arnautovic, I., Helenowski, I. & Sharrack, B., Nov 1 2020, In: Journal of Neurology. 267, 11, p. 3378-3391 14 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rβ1 internalization and suppress EAE
Mondal, S., Kundu, M., Jana, M., Roy, A., Rangasamy, S. B., Modi, K. K., Wallace, J., Albalawi, Y. A., Balabanov, R. & Pahan, K., Sep 1 2020, In: Proceedings of the National Academy of Sciences of the United States of America. 117, 35, p. 21557-21567 11 p.Research output: Contribution to journal › Article › peer-review
-
Pre-clinical and Clinical Implications of “Inside-Out” vs. “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis
Titus, H. E., Chen, Y., Podojil, J. R., Robinson, A. P., Balabanov, R., Popko, B. & Miller, S. D., Oct 27 2020, In: Frontiers in Cellular Neuroscience. 14, 599717.Research output: Contribution to journal › Review article › peer-review
Open Access -
Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica
Burt, R. K., Balabanov, R., Han, X., Burns, C., Gastala, J., Jovanovic, B., Helenowski, I., Jitprapaikulsan, J., Fryer, J. P. & Pittock, S. J., Oct 29 2019, In: Neurology. 93, 18, p. E1732-E1741Research output: Contribution to journal › Article › peer-review
13 Scopus citations -
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial
Burt, R. K., Balabanov, R., Burman, J., Sharrack, B., Snowden, J. A., Oliveira, M. C., Fagius, J., Rose, J., Nelson, F., Barreira, A. A., Carlson, K., Han, X., Moraes, D., Morgan, A., Quigley, K., Yaung, K., Buckley, R., Alldredge, C., Clendenan, A., Calvario, M. A. & 3 others, , Jan 15 2019, In: JAMA - Journal of the American Medical Association. 321, 2, p. 165-174 10 p.Research output: Contribution to journal › Article › peer-review
68 Scopus citations